… 4.2 Human immunomodulating agents Immunomodulatory disease-modifying agents
used in human medicine for remitting-relapsing immune-mediated diseases may merit …

… recombinant immunomodulators discussed in this review succinctly demonstrate the
potential of these agents to stimulate host defense mechanisms for prophylaxis and treatment of …

… agents are the cause of the infection, 5 investigation of their potential role as immunomodulatory
agents in all… Recommendations for adjunctive therapy with immunomodulatory agents in …

… the emergence of immunomodulators as promising therapeutic agents in infectious diseases…
thetic and natural immunomodulatory preparations for prophylaxis and treatment of various …

… immunomodulatory agents (IMAs) have been available as first-line therapies for the treatment
… clinicians have effective agents to choose from, selecting the appropriate treatment can be …

… Increasing the capacity of the MPS by administration of immunomodulatory agents, both …
after intravenous administration, the immunomodulatory agents are administered at rather high …

Objective Coronavirus disease 2019 (COVID-19) is a world-wide pandemic caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To date, treatment of severe …

Simple Summary This review focuses on the effects that a class of drugs, PI3Kδ inhibitors,
used for the treatment of patients with lymphoma can have not on the neoplastic cells but on …

… RCTs/CCTs utilising non-corticosteroid immunosuppressive, anti-fibrotic or immunomodulatory
agents versus either placebo or corticosteroids alone in adult patients with histological …

… In this Perspective, the concept of treatment approaches using immunomodulatory
agents and the latest advances of therapies in autoimmune systemic inflammatory diseases, …